{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T16:51:41Z","timestamp":1764089501049,"version":"3.45.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,25]]},"DOI":"10.7759\/cureus.97762","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T16:46:21Z","timestamp":1764089181000},"source":"Crossref","is-referenced-by-count":0,"title":["A Brief Report on Outcomes of Metastatic Non-Small Cell Lung Cancer: A Retrospective Observational Study in a Community Practice Setting"],"prefix":"10.7759","author":[{"given":"Brandon","family":"Poppe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa S","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neel","family":"Dharia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad C","family":"Cherington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puneet","family":"Bhalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James I","family":"Ewing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Sud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujith","family":"Kalmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh K","family":"Ramanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azam","family":"Farooqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer","volume":"553","author":"Herbst RS","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018, 553:446-54. 10.1038\/nature25183","journal-title":"Nature"},{"key":"ref2","unstructured":"NCI dictionary of cancer terms. (2020). Accessed. July 08, 2025: https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/pore.2024.1611715","article-title":"Targeted therapeutic options in early and metastatic NSCLC-overview","volume":"30","author":"G\u00e1lffy G","year":"2024","unstructured":"G\u00e1lffy G, Mor\u00f3cz \u00c9, Korompay R, et al.. Targeted therapeutic options in early and metastatic NSCLC-overview. Pathol Oncol Res. 2024, 30:1611715. 10.3389\/pore.2024.1611715","journal-title":"Pathol Oncol Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000000725","article-title":"Community-based cancer care quality and expertise in a COVID-19 era and beyond","volume":"43","author":"Garg AK","year":"2020","unstructured":"Garg AK. Community-based cancer care quality and expertise in a COVID-19 era and beyond. Am J Clin Oncol. 2020, 43:537-8. 10.1097\/COC.0000000000000725","journal-title":"Am J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16071414","article-title":"Real-world data and evidence in lung cancer: A review of recent developments","volume":"16","author":"Kokkotou E","year":"2024","unstructured":"Kokkotou E, Anagnostakis M, Evangelou G, et al.. Real-world data and evidence in lung cancer: A review of recent developments. Cancers, vol. 16, no. 7. 2024, 16:1414. 10.3390\/cancers16071414","journal-title":"Cancers, vol. 16, no. 7"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01100-2018","article-title":"Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer","volume":"52","author":"Cramer-van der Welle CM","year":"2018","unstructured":"Cramer-van der Welle CM, Peters BJ, Schramel FM, Klungel OH, Groen HJ, van de Garde EM. Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer. Eur Respir J. 2018, 52:1801100. 10.1183\/13993003.01100-2018","journal-title":"Eur Respir J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910231","article-title":"Nivolumab plus ipilimumab in advanced non-small-cell lung cancer","volume":"381","author":"Hellmann MD","year":"2019","unstructured":"Hellmann MD, Paz-Ares L, Bernabe Caro R, et al.. Nivolumab plus ipilimumab in advanced non-small-cell lung cancer. N Engl J Med. 2019, 381:2020-31. 10.1056\/NEJMoa1910231","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer","volume":"375","author":"Reck M","year":"2016","unstructured":"Reck M, Rodr\u00edguez-Abreu D, Robinson AG, et al.. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer. N Engl J Med. 2016, 375:1823-33. 10.1056\/NEJMoa1606774","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.03136","article-title":"Updated analysis from KEYNOTE-189: Pembrolizumab or placebo plus pemetrexed and platinum for previously untreated metastatic nonsquamous non-small-cell lung cancer","volume":"38","author":"Gadgeel S","year":"2020","unstructured":"Gadgeel S, Rodr\u00edguez-Abreu D, Speranza G, et al.. Updated analysis from KEYNOTE-189: Pembrolizumab or placebo plus pemetrexed and platinum for previously untreated metastatic nonsquamous non-small-cell lung cancer. J Clin Oncol. 2020, 38:1505-17. 10.1200\/JCO.19.03136","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1200\/GO.20.00629","article-title":"Assessment of brain metastasis at diagnosis in non-small-cell lung cancer: A prospective observational study from North India","volume":"7","author":"Naresh G","year":"2021","unstructured":"Naresh G, Malik PS, Khurana S, et al.. Assessment of brain metastasis at diagnosis in non-small-cell lung cancer: A prospective observational study from North India. JCO Glob Oncol. 2021, 7:593-601. 10.1200\/GO.20.00629","journal-title":"JCO Glob Oncol"},{"key":"ref11","unstructured":"American Lung Association. State of lung cancer - Arizona. (2025). Accessed: July 08, 2025: https:\/\/www.lung.org\/research\/state-of-lung-cancer\/states\/arizona."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21404","article-title":"Charting the future of cancer health disparities research: A position statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute","volume":"67","author":"Polite BN","year":"2017","unstructured":"Polite BN, Adams-Campbell LL, Brawley OW, et al.. Charting the future of cancer health disparities research: A position statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute. CA Cancer J Clin. 2017, 67:353-61. 10.3322\/caac.21404","journal-title":"CA Cancer J Clin"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35944","article-title":"An examination of factors associated with disparities in clinical trial eligibility guided by the socioecological model","volume":"131","author":"Zhao Y","year":"2025","unstructured":"Zhao Y, Amorrortu RP, Hicks JK, et al.. An examination of factors associated with disparities in clinical trial eligibility guided by the socioecological model. Cancer. 2025, 131:e35944. 10.1002\/cncr.35944","journal-title":"Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-3852","article-title":"Continuing to broaden eligibility criteria to make clinical trials more representative and inclusive: ASCO-Friends of Cancer Research joint research statement","volume":"27","author":"Kim ES","year":"2021","unstructured":"Kim ES, Uldrick TS, Schenkel C, et al.. Continuing to broaden eligibility criteria to make clinical trials more representative and inclusive: ASCO-Friends of Cancer Research joint research statement. Clin Cancer Res. 2021, 27:2394-9. 10.1158\/1078-0432.CCR-20-3852","journal-title":"Clin Cancer Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/431985-a-brief-report-on-outcomes-of-metastatic-non-small-cell-lung-cancer-a-retrospective-observational-study-in-a-community-practice-setting","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T16:46:23Z","timestamp":1764089183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/431985-a-brief-report-on-outcomes-of-metastatic-non-small-cell-lung-cancer-a-retrospective-observational-study-in-a-community-practice-setting"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.97762","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,11,25]]}}}